UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Die Ausbildungs- und Berufssituation contergangeschädigter junger Erwachsener

Rehabilitation (Stuttgart), 1989, Vol.28 (2), p.78-82

Moltke, H.-J. von

1989

Volltextzugriff (PDF)

Le financement du progrès technologique au regard des objectifs de la politique industrielle de la Communauté

Revue du Marche Commun et de l'Union Europeenne, 1972-03, p.236-247

Von Moltke, H

1972

Volltextzugriff (PDF)

A German of the resistance: the last letters of Count Helmuth James von Moltke

Central News Agency, Ltd., 1947. 28 pp, 1947

von Moltke, H J

1947

Volltextzugriff (PDF)

MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation

The Journal of experimental medicine, 2017-12, Vol.214 (12), p.3627-3643

2017

Volltextzugriff (PDF)

NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and -8

Immunity (Cambridge, Mass.), 2017-04, Vol.46 (4), p.649-659

2017

Volltextzugriff (PDF)

Antioxidant content and activity of the seaweed Saccharina latissima: a seasonal perspective

Journal of applied phycology, 2019-04, Vol.31 (2), p.1343-1354

2019

Volltextzugriff (PDF)

Interactions between Iron, Phenolic Compounds, Emulsifiers, and pH in Omega-3-Enriched Oil-in-Water Emulsions

Journal of agricultural and food chemistry, 2008-03, Vol.56 (5), p.1740-1750

2008

Volltextzugriff (PDF)

Rapid induction of inflammatory lipid mediators by the inflammasome in vivo

Nature (London), 2012-10, Vol.490 (7418), p.107-111

2012

Volltextzugriff (PDF)

Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse

Nature (London), 2013-07, Vol.499 (7456), p.74-78

2013

Volltextzugriff (PDF)

Preliminary Safety Results of the Open-Label Phase of a 2-Part Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Cell Transplantation

Blood, 2023-11, Vol.142 (Supplement 1), p.6994-6994

2023

Volltextzugriff (PDF)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)

Antibiotics (Basel), 2022-09, Vol.11 (9), p.1234

2022

Volltextzugriff (PDF)

694 DURABILITY OF THE CLINICAL RESPONSE TO SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN A PHASE 3 OPEN-LABEL TRIAL (ECOSPOR IV) IN PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-140-S-140

2023

Volltextzugriff (PDF)

Su1873 RESULTS FROM AN OPEN-LABEL STUDY (ECOSPOR IV) TO EVALUATE THE SAFETY AND EFFICACY OF SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN ADULTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (RCDI): A SUBGROUP ANALYSIS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-699-S-700

2023

Volltextzugriff (PDF)

P.755 ALKS 3831, a combination of olanzapine and samidorphan, has no clinically relevant effect on QT prolongation up to supratherapeutic doses

European neuropsychopharmacology, 2019-12, Vol.29, p.S507-S508

2019

Volltextzugriff (PDF)

Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice

Drug metabolism and disposition, 2007-07, Vol.35 (7), p.1223-1231

2007

Volltextzugriff (PDF)

Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity

Drug metabolism and disposition, 2005-12, Vol.33 (12), p.1827

2005

Volltextzugriff (PDF)

Moving Health Sovereignty in Africa: Disease, Governance, Climate Change

1, 2014

Volltextzugriff (PDF)

634. Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides difficile Infection (CDI) Compared to Placebo, Regardless of Risk Factors for Recurrence

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S420-S420

2021

Volltextzugriff (PDF)

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

Infectious diseases and therapy, 2024-10, Vol.13 (10), p.2105-2121

2024

Volltextzugriff (PDF)

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

Infectious diseases and therapy, 2024-10, Vol.13 (10), p.2209-2210

2024

Volltextzugriff (PDF)

LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S812-S813

2021

Volltextzugriff (PDF)

Deep primary production in coastal pelagic systems: importance for ecosystem functioning

Marine ecology. Progress series (Halstenbek), 2014-12, Vol.517, p.15-33

2014

Volltextzugriff (PDF)

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent IClostridioides difficile/I Infection

Antibiotics (Basel), 2022-09, Vol.11 (9)

2022

Volltextzugriff (PDF)

Africa's Health Challenges: Sovereignty, Mobility of People and Healthcare Governance

1, 2013

Volltextzugriff (PDF)

EVALUATION OF 5-HYDROXYTRYPTOPHOL AND OTHER ENDOGENOUS SEROTONIN (5-HYDROXYTRYPTAMINE) ANALOGS AS SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 1A6

Drug metabolism and disposition, 2004-08, Vol.32 (8), p.862-869

2004

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(37)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Die Ausbildungs- und Berufssituation contergangeschädigter junger Erwachsener

Le financement du progrès technologique au regard des objectifs de la politique industrielle de la Communauté

A German of the resistance: the last letters of Count Helmuth James von Moltke

MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation

NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and -8

Antioxidant content and activity of the seaweed Saccharina latissima: a seasonal perspective

Interactions between Iron, Phenolic Compounds, Emulsifiers, and pH in Omega-3-Enriched Oil-in-Water Emulsions

Rapid induction of inflammatory lipid mediators by the inflammasome in vivo

Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse

Preliminary Safety Results of the Open-Label Phase of a 2-Part Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Cell Transplantation

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)

694 DURABILITY OF THE CLINICAL RESPONSE TO SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN A PHASE 3 OPEN-LABEL TRIAL (ECOSPOR IV) IN PATIENTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION

Su1873 RESULTS FROM AN OPEN-LABEL STUDY (ECOSPOR IV) TO EVALUATE THE SAFETY AND EFFICACY OF SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN ADULTS WITH RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION (RCDI): A SUBGROUP ANALYSIS

P.755 ALKS 3831, a combination of olanzapine and samidorphan, has no clinically relevant effect on QT prolongation up to supratherapeutic doses

Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice

Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity

Moving Health Sovereignty in Africa: Disease, Governance, Climate Change

634. Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides difficile Infection (CDI) Compared to Placebo, Regardless of Risk Factors for Recurrence

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI

LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics

Deep primary production in coastal pelagic systems: importance for ecosystem functioning

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent IClostridioides difficile/I Infection

Africa's Health Challenges: Sovereignty, Mobility of People and Healthcare Governance

EVALUATION OF 5-HYDROXYTRYPTOPHOL AND OTHER ENDOGENOUS SEROTONIN (5-HYDROXYTRYPTAMINE) ANALOGS AS SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 1A6

Aktive Filter

Suchergebnisse filtern